CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
- 30 June 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 172 (6), 1650-1663
- https://doi.org/10.2353/ajpath.2008.071049
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- TLR‐mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cellsEuropean Journal of Immunology, 2007
- Toll-like receptors in systemic autoimmune diseaseNature Reviews Immunology, 2006
- In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF- in the lungThorax, 2006
- B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic SclerosisThe American Journal of Pathology, 2006
- Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient MiceCirculation, 2004
- Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 SignalingThe Journal of Experimental Medicine, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4The Journal of Experimental Medicine, 2002
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Rat Alveolar Macrophage Cytokine Production and Regulation of Neutrophil Recruitment Following Acute Ozone ExposureToxicology and Applied Pharmacology, 1997